Addiction

KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first…

5 months ago

Odyssey House Implements Oracle Health to Help Enhance Patient Care, Improve Revenue Management

Utah-based mental health organization integrates EHR and behavioral health solutions to help deliver a better care experience for patients and…

5 months ago

Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition

CEO of Custom Health and Executive Director of the American Medical Technology Coalition Shane Bishop announced the launch of the…

5 months ago

Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith

Over 100,000 individuals lost their lives from overdoses last year, the majority of which were opioid related. While opioid overdoses…

5 months ago

Transforming Lives Through Affordable and Structured Sober Living

Tom Fay's Vision Expands Gambit Recovery Nationwide, Providing a Safe Haven for Individuals Battling Substance Abuse CHANDLER, AZ / ACCESSWIRE…

5 months ago

Hazelden Betty Ford Reports Latest Treatment Results, Patient Outcomes

Helping People Outlive the Disease of AddictionCenter City, Minnesota--(Newsfile Corp. - July 23, 2024) - As the U.S. confronts a…

5 months ago

Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research

Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authoritiesVancouver,…

5 months ago

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Patient dosing in the second cohort has commenced following the successful completion of the first cohortGLEN ALLEN, Va., July 23,…

5 months ago

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

5 months ago

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

5 months ago